Solutions for Researchers - Medical / Health Care - Medical Research
BostonGene supports academic researchers and life science companies to build a future without cancer. As a research partner, BostonGene provides access to a wide spectrum of cutting-edge technologies to develop and validate novel precision medicine approaches.
-
Most popular related searches
Details
Laboratory services
A comprehensive portfolio of multiomics laboratory solutions. Use our multiomics laboratory capacity and techniques to analyze a vast array of sample types.
- From sample preparation to data delivery
- Additional top-off sequencing for low-quality samples
- Only pay for samples that pass quality control
- CAP and CLIA-certified laboratory
- DNA sequencing
- Whole-exome sequencing (WES) detects genomic alterations, copy number variations (CNVs), loss of heterozygosity (LOH), tumor mutational burden (TMB), and microsatellite instability (MSI) status with high precision.
- RNA sequencing (RNA-seq)
- Expression profiles of more than 20,000 genes to uncover the activity of biological processes in every sample. Our clinically validated RNA-seq gene fusion and chromosomal rearrangement detection assays offer additional insights into the molecular profile.
- ctDNA and ctRNA analysis
- Comprehensive molecular analysis of peripheral blood for non-invasive disease detection and monitoring.
- TCR/BCR targeted sequencing
- Deep sequencing is available for T cell and B cell receptor repertoires.
- Large immunohistochemistry antibody panels can be customized based on the research needs. A combination of a highly experienced pathology team with AI-based algorithms provides deep analyses of cell populations and tissue architecture.
- Multiplex immunofluorescence (MxIF)
- Study the expression of up to 40 different cell markers in a single FFPE slide with single-cell resolution. BostonGene panels are designed to give a comprehensive overview of tissue architecture, tumor-stroma border regions, immune cell infiltration, and advanced analytics of cell-to-cell interactions.
- Flow cytometry
- Clinically validated extended marker panel detects more than 350 cell populations in blood or tissue samples.
